z-logo
open-access-imgOpen Access
Inhibition of cAMP-Activated Intestinal Chloride Secretion by Diclofenac: Cellular Mechanism and Potential Application in Cholera
Author(s) -
Pawin Pongkorpsakol,
Nutthapoom Pathomthongtaweechai,
Potjanee Srimanote,
Sunhapas Soodvilai,
Varanuj Chatsudthipong,
Chatchai Muanprasat
Publication year - 2014
Publication title -
plos neglected tropical diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.99
H-Index - 135
eISSN - 1935-2735
pISSN - 1935-2727
DOI - 10.1371/journal.pntd.0003119
Subject(s) - diclofenac , secretion , vibrio cholerae , cholera toxin , chloride channel , apical membrane , chemistry , cholera , microbiology and biotechnology , biology , biochemistry , endocrinology , membrane , genetics , bacteria
Cyclic AMP-activated intestinal Cl − secretion plays an important role in pathogenesis of cholera. This study aimed to investigate the effect of diclofenac on cAMP-activated Cl − secretion, its underlying mechanisms, and possible application in the treatment of cholera. Diclofenac inhibited cAMP-activated Cl − secretion in human intestinal epithelial (T84) cells with IC 50 of ∼20 µM. The effect required no cytochrome P450 enzyme-mediated metabolic activation. Interestingly, exposures of T84 cell monolayers to diclofenac, either in apical or basolateral solutions, produced similar degree of inhibitions. Analyses of the apical Cl − current showed that diclofenac reversibly inhibited CFTR Cl − channel activity (IC 50 ∼10 µM) via mechanisms not involving either changes in intracellular cAMP levels or CFTR channel inactivation by AMP-activated protein kinase and protein phosphatase. Of interest, diclofenac had no effect on Na + -K + ATPases and Na + -K + -Cl − cotransporters, but inhibited cAMP-activated basolateral K + channels with IC 50 of ∼3 µM. In addition, diclofenac suppressed Ca 2+ -activated Cl − channels, inwardly rectifying Cl − channels, and Ca 2+ -activated basolateral K + channels. Furthermore, diclofenac (up to 200 µM; 24 h of treatment) had no effect on cell viability and barrier function in T84 cells. Importantly, cholera toxin (CT)-induced Cl − secretion across T84 cell monolayers was effectively suppressed by diclofenac. Intraperitoneal administration of diclofenac (30 mg/kg) reduced both CT and Vibrio cholerae -induced intestinal fluid secretion by ∼70% without affecting intestinal fluid absorption in mice. Collectively, our results indicate that diclofenac inhibits both cAMP-activated and Ca 2+ -activated Cl − secretion by inhibiting both apical Cl − channels and basolateral K + channels in intestinal epithelial cells. Diclofenac may be useful in the treatment of cholera and other types of secretory diarrheas resulting from intestinal hypersecretion of Cl − .

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom